{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:52:50Z","timestamp":1791381170762,"version":"4.3.3"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Perfluorinated alkylate substances (PFASs) have been in use for about 75 years. Because of their persistence, concentrations in the environment have increased, and absorbed PFAS will remain in the human body, some compounds for many years. The fetus and the newborn infant are particularly vulnerable to PFAS toxicity due to the intense development of organs and body functions. In addition, PFASs pass the placenta so that a pregnant woman shares her accumulated PFAS burden with the progeny. In addition, PFASs are excreted in the milk, so that the resulting serum-PFAS concentration in the infant may greatly exceed that of the mother. Multi-organ effects have been reported, some related to endocrine disruption. Immunotoxicity can occur at very low exposure levels, with elevated risks of infectious disease and possibly also cancer development. Unfortunately, little research was carried out during the first 50 years of industrial use, and some study reports were hidden. Independent research has been carried out only recently. Due to incomplete evidence, governmental regulations have been delayed and remain insufficient, in part because of objections from industrial interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>The perfluorinated alkylate substances (PFASs) are persistent and accumulate in the environment and in the human body. The greatest risk of PFAS toxicity occurs at early age, as PFASs are transferred through the placenta and human milk. This means that early-life exposures may trigger development of diseases and other adverse outcomes that may seriously burden adult health. Research has been delayed due to secrecy. While pediatric\u00a0studies in this field are underway, prudent decisions to protect public health should be made despite possible concerns regarding incomplete evidence.<\/jats:p>\n                    <jats:p>\n                      Practical complications, and current guidelines and interventions are by far insufficient.\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Current evidence on PFASs shows that these industrial chemicals are persistent and that highly elevated exposures occur already at early age.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The maternal body burden of PFAS is shared with the fetus, and substantial amounts are transferred in human milk, thus impacting the unique nutritional advantage of breast-feeding.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Recent evidence suggests that early PFAS exposure can affect public health, also during adult age, and that some adverse effects may be transferred to the next generation.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05366-w","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:08:08Z","timestamp":1791371288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric effects of forever chemicals may last for a long time"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-9658","authenticated-orcid":false,"given":"Philippe","family":"Grandjean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"5366_CR1","unstructured":"Agency for Toxic Substances and Disease Registry. Toxicological Profile for Perfluoroalkyls. (Centers For Disease Control, Atlanta, GA, 2021)."},{"key":"5366_CR2","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1039\/D0EM00291G","volume":"22","author":"J Gluge","year":"2020","unstructured":"Gluge, J. et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ. Sci. Process Impacts 22, 2345\u20132373 (2020).","journal-title":"Environ. Sci. Process Impacts"},{"key":"5366_CR3","unstructured":"Faber, S. EPA on \u2018Forever chemicals\u2019: let them drink polluted water. Hill. https:\/\/thehill.com\/opinion\/energy-environment\/463826-epa-on-forever-chemicals-let-them-drink-polluted-water. (2019)."},{"key":"5366_CR4","unstructured":"U.S. Environmental Protection Agency. 2010\/2015 PFOA Stewardship Program, http:\/\/www.epa.gov\/oppt\/pfoa\/pubs\/stewardship\/index.html (2006)."},{"key":"5366_CR5","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1021\/es900228k","volume":"43","author":"R Vestergren","year":"2009","unstructured":"Vestergren, R. & Cousins, I. T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 43, 5565\u20135575 (2009).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR6","doi-asserted-by":"crossref","unstructured":"Brennan, N. M., Evans, A. T., Fritz, M. K., Peak, S. A. & von Holst, H. E. Trends in the regulation of per- and polyfluoroalkyl substances (PFAS): a scoping review. Int. J. Environ. Res. Public Health 18, 10900 (2021).","DOI":"10.3390\/ijerph182010900"},{"key":"5366_CR7","first-page":"1","volume":"653","author":"European Food Safety Authority","year":"2008","unstructured":"European Food Safety Authority Opinion of the scientific panel on contaminants in the food chain on perfluorooctane sulfonate (PFOS), Perfluorooctanoic Acid (PFOA) and their salts. EFSA J. 653, 1\u2013131 (2008).","journal-title":"EFSA J."},{"key":"5366_CR8","doi-asserted-by":"publisher","first-page":"106415","DOI":"10.1016\/j.envint.2021.106415","volume":"151","author":"SM Seshasayee","year":"2021","unstructured":"Seshasayee, S. M. et al. Dietary patterns and PFAS plasma concentrations in childhood: project VIVA, USA. Environ. Int. 151, 106415 (2021).","journal-title":"Environ. Int"},{"key":"5366_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.110284","volume":"192","author":"A Augustsson","year":"2021","unstructured":"Augustsson, A. et al. Consumption of freshwater fish: a variable but significant risk factor for PFOS exposure. Environ. Res 192, 110284 (2021).","journal-title":"Environ. Res"},{"key":"5366_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2022.114057","volume":"247","author":"D Richterova","year":"2023","unstructured":"Richterova, D. et al. PFAS levels and determinants of variability in exposure in European teenagers - results from the HBM4EU aligned Studies (2014-2021). Int. J. Hyg. Environ. Health 247, 114057 (2023).","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"5366_CR11","doi-asserted-by":"publisher","first-page":"107549","DOI":"10.1016\/j.envint.2022.107549","volume":"169","author":"K Abraham","year":"2022","unstructured":"Abraham, K. & Monien, B. H. Transdermal absorption of (13)C(4)-Perfluorooctanoic Acid ((13)C(4)-PFOA) from a sunscreen in a male volunteer - what could be the contribution of cosmetics to the internal exposure of perfluoroalkyl substances (PFAS)?. Environ. Int. 169, 107549 (2022).","journal-title":"Environ. Int"},{"key":"5366_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1289\/ehp.10009","volume":"115","author":"GW Olsen","year":"2007","unstructured":"Olsen, G. W. et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115, 1298\u20131305 (2007).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR13","doi-asserted-by":"publisher","DOI":"10.1289\/EHP10103","volume":"130","author":"WA Chiu","year":"2022","unstructured":"Chiu, W. A. et al. Bayesian estimation of human population toxicokinetics of PFOA, PFOS, PFHxS, and PFNA from studies of contaminated drinking water. Environ. Health Perspect. 130, 127001 (2022).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR14","doi-asserted-by":"publisher","first-page":"117743","DOI":"10.1016\/j.envres.2023.117743","volume":"242","author":"I Rosato","year":"2024","unstructured":"Rosato, I. et al. Estimation of Per- and Polyfluoroalkyl Substances (PFAS) half-lives in human studies: a systematic review and meta-analysis. Environ. Res. 242, 117743 (2024).","journal-title":"Environ. Res."},{"key":"5366_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.chemosphere.2014.07.061","volume":"129","author":"MH Russell","year":"2015","unstructured":"Russell, M. H., Waterland, R. L. & Wong, F. Calculation of chemical elimination half-life from blood with an ongoing exposure source: the example of Perfluorooctanoic Acid (PFOA). Chemosphere 129, 210\u2013216 (2015).","journal-title":"Chemosphere"},{"key":"5366_CR16","unstructured":"National Academies of Sciences, Engineering, and Medicine. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (The National Academies Press, 2022)."},{"key":"5366_CR17","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.1021\/acs.est.0c06978","volume":"55","author":"G Zheng","year":"2021","unstructured":"Zheng, G. et al. Per- and polyfluoroalkyl substances (PFAS) in breast milk: concerning trends for current-use PFAS. Environ. Sci. Technol. 55, 7510\u20137520 (2021).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR18","unstructured":"C8 Science Panel. Probable link evaluation of pregnancy induced hypertension and preeclampsia. http:\/\/www.c8sciencepanel.org\/ (2011)."},{"key":"5366_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.114284","volume":"215","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Associations of perfluoroalkyl and polyfluoroalkyl substances with gestational hypertension and blood pressure during pregnancy: a cohort study. Environ. Res. 215, 114284 (2022).","journal-title":"Environ. Res."},{"key":"5366_CR20","doi-asserted-by":"publisher","first-page":"e0123496","DOI":"10.1371\/journal.pone.0123496","volume":"10","author":"TK Jensen","year":"2015","unstructured":"Jensen, T. K. et al. Association between perfluorinated compound exposure and miscarriage in Danish pregnant women. PLoS ONE 10, e0123496 (2015).","journal-title":"PLoS ONE"},{"key":"5366_CR21","doi-asserted-by":"crossref","unstructured":"Haimbaugh, A. et al. Environmental Exposure to Per- and Polyfluorylalkyl Substances (PFASs) and reproductive outcomes in the general population: a systematic review of epidemiological studies. Int. J. Environ. Res. Public Health 21, 1615 (2024).","DOI":"10.3390\/ijerph21121615"},{"key":"5366_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/humrep\/deu350","volume":"30","author":"MP Velez","year":"2015","unstructured":"Velez, M. P., Arbuckle, T. E. & Fraser, W. D. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Hum. Reprod. 30, 701\u2013709 (2015).","journal-title":"Hum. Reprod."},{"key":"5366_CR23","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1007\/s11356-022-24785-w","volume":"30","author":"D Szczesna","year":"2023","unstructured":"Szczesna, D., Wieczorek, K. & Jurewicz, J. An exposure to endocrine active persistent pollutants and endometriosis - a review of current epidemiological studies. Environ. Sci. Pollut. Res. Int. 30, 13974\u201313993 (2023).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"5366_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107567","volume":"170","author":"K Luo","year":"2022","unstructured":"Luo, K. et al. Preconception exposure to perfluoroalkyl and polyfluoroalkyl substances and couple fecundity: a couple-based exploration. Environ. Int. 170, 107567 (2022).","journal-title":"Environ. Int"},{"key":"5366_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.116159","volume":"269","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. Parental plasma concentrations of perfluoroalkyl substances and in vitro fertilization outcomes. Environ. Pollut. 269, 116159 (2021).","journal-title":"Environ. Pollut."},{"key":"5366_CR26","doi-asserted-by":"publisher","first-page":"27002","DOI":"10.1289\/EHP10857","volume":"131","author":"XW Zeng","year":"2023","unstructured":"Zeng, X. W. et al. Perfluoroalkyl acids in follicular fluid and embryo quality during IVF: a prospective IVF cohort in China. Environ. Health Perspect. 131, 27002 (2023).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/EDE.0b013e31823b5031","volume":"23","author":"KW Whitworth","year":"2012","unstructured":"Whitworth, K. W. et al. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 23, 257\u2013263 (2012).","journal-title":"Epidemiology"},{"key":"5366_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1114463","volume":"14","author":"Z Sun","year":"2023","unstructured":"Sun, Z. et al. Toxic effects of per- and polyfluoroalkyl substances on sperm: epidemiological and experimental evidence. Front. Endocrinol. 14, 1114463 (2023).","journal-title":"Front. Endocrinol."},{"key":"5366_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10408444.2016.1182117","volume":"46","author":"CC Bach","year":"2016","unstructured":"Bach, C. C. et al. Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review. Crit. Rev. Toxicol. 46, 735\u2013755 (2016).","journal-title":"Crit. Rev. Toxicol."},{"key":"5366_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1289\/ehp.0800517","volume":"117","author":"UN Joensen","year":"2009","unstructured":"Joensen, U. N. et al. Do perfluoroalkyl compounds impair human semen quality?. Environ. Health Perspect. 117, 923\u2013927 (2009).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR31","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/humrep\/des185","volume":"27","author":"G Toft","year":"2012","unstructured":"Toft, G. et al. Exposure to perfluorinated compounds and human semen quality in arctic and European populations. Hum. Reprod. 27, 2532\u20132540 (2012).","journal-title":"Hum. Reprod."},{"key":"5366_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1289\/ehp.1205118","volume":"121","author":"A Vested","year":"2013","unstructured":"Vested, A. et al. Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men. Environ. Health Perspect. 121, 453\u2013458 (2013).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR33","doi-asserted-by":"publisher","DOI":"10.1289\/EHP10285","volume":"130","author":"KK Haervig","year":"2022","unstructured":"Haervig, K. K. et al. Maternal exposure to per- and polyfluoroalkyl substances (PFAS) and male reproductive function in young adulthood: combined exposure to seven PFAS. Environ. Health Perspect. 130, 107001 (2022).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR34","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1289\/ehp.10334","volume":"115","author":"BJ Apelberg","year":"2007","unstructured":"Apelberg, B. J. et al. Cord serum concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 115, 1670\u20131676 (2007).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1289\/ehp.1307893","volume":"122","author":"PI Johnson","year":"2014","unstructured":"Johnson, P. I. et al. The navigation guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122, 1028\u20131039 (2014).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-020-00591-0","volume":"19","author":"G Waterfield","year":"2020","unstructured":"Waterfield, G. et al. Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota. Environ. Health 19, 42 (2020).","journal-title":"Environ. Health"},{"key":"5366_CR37","doi-asserted-by":"publisher","first-page":"89805","DOI":"10.1007\/s11356-023-28458-0","volume":"30","author":"L Lan","year":"2023","unstructured":"Lan, L. et al. Associations between maternal exposure to perfluoroalkylated substances (PFASs) and infant birth weight: a meta-analysis. Environ. Sci. Pollut. Res. Int. 30, 89805\u201389822 (2023).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"5366_CR38","unstructured":"U.S. Environmental Protection Agency. Per- and Polyfluoroalkyl Substances (PFAS). https:\/\/www.epa.gov\/sdwa\/and-polyfluoroalkyl-substances-pfas. (2023)."},{"key":"5366_CR39","unstructured":"European Food Safety Authority. Risk to human health related to the presence of perfluoroalkyl substances in food. https:\/\/www.efsa.europa.eu\/en\/efsajournal\/pub\/6223EFSA J. 18, e06223 (2020)."},{"key":"5366_CR40","unstructured":"WHO. Keeping our water clean: the case of water contamination in the Veneto region, Italy (Regional Office for Europe, World Health Organization, 2016, https:\/\/www.who.int\/europe\/publications\/i\/item\/97892890524672016)."},{"key":"5366_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.reprotox.2016.08.002","volume":"68","author":"M Karlsen","year":"2017","unstructured":"Karlsen, M. et al. Early-life exposures to persistent organic pollutants in relation to overweight in preschool children. Reprod. Toxicol. 68, 145\u2013153 (2017).","journal-title":"Reprod. Toxicol."},{"key":"5366_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2025.121814","volume":"279","author":"M Ouidir","year":"2025","unstructured":"Ouidir, M. et al. PFAS exposures and child growth: a longitudinal study from fetal life to early childhood. Environ. Res. 279, 121814 (2025).","journal-title":"Environ. Res."},{"key":"5366_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-023-01006-6","volume":"22","author":"G Frigerio","year":"2023","unstructured":"Frigerio, G., Ferrari, C. M. & Fustinoni, S. Prenatal and childhood exposure to Per-\/Polyfluoroalkyl substances (PFASs) and its associations with childhood overweight and\/or obesity: a systematic review with meta-analyses. Environ. Health 22, 56 (2023).","journal-title":"Environ. Health"},{"key":"5366_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106567","volume":"154","author":"Y Ou","year":"2021","unstructured":"Ou, Y. et al. Gestational exposure to perfluoroalkyl substances and congenital heart defects: a nested case-control pilot study. Environ. Int. 154, 106567 (2021).","journal-title":"Environ. Int."},{"key":"5366_CR45","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/S2542-5196(23)00257-7","volume":"8","author":"T Hyotylainen","year":"2024","unstructured":"Hyotylainen, T. et al. In utero exposures to Perfluoroalkyl substances and the human fetal liver metabolome in Scotland: a cross-sectional study. Lancet Planet Health 8, e5\u2013e17 (2024).","journal-title":"Lancet Planet Health"},{"key":"5366_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.170905","volume":"919","author":"M Qiu","year":"2024","unstructured":"Qiu, M. et al. Reprogramming of DNA methylation patterns mediates perfluorooctane sulfonate-induced fetal cardiac dysplasia. Sci. Total Environ. 919, 170905 (2024).","journal-title":"Sci. Total Environ."},{"key":"5366_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116064","volume":"231","author":"CY Hu","year":"2023","unstructured":"Hu, C. Y. et al. Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Environ. Res. 231, 116064 (2023).","journal-title":"Environ. Res."},{"key":"5366_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82748-6","volume":"11","author":"S Wikstrom","year":"2021","unstructured":"Wikstrom, S. et al. Exposure to perfluoroalkyl substances in early pregnancy and risk of sporadic first trimester miscarriage. Sci. Rep. 11, 3568 (2021).","journal-title":"Sci. Rep."},{"key":"5366_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2019.109101","volume":"182","author":"RC Jensen","year":"2020","unstructured":"Jensen, R. C. et al. Prenatal exposure to perfluorodecanoic acid is associated with lower circulating concentration of adrenal steroid metabolites during mini puberty in human female infants. The Odense Child Cohort. Environ. Res. 182, 109101 (2020).","journal-title":"Environ. Res."},{"key":"5366_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117553","volume":"241","author":"L Li","year":"2024","unstructured":"Li, L. et al. Association between exposure to per- and perfluoroalkyl substances (PFAS) and reproductive hormones in human: a systematic review and meta-analysis. Environ. Res. 241, 117553 (2024).","journal-title":"Environ. Res"},{"key":"5366_CR51","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1289\/ehp.1408847","volume":"123","author":"M Maisonet","year":"2015","unstructured":"Maisonet, M. et al. Prenatal exposure to perfluoroalkyl acids and serum testosterone concentrations at 15 years of age in female ALSPAC study participants. Environ. Health Perspect. 123, 1325\u20131330 (2015).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR52","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1289\/ehp.1509869","volume":"124","author":"MJ Lopez-Espinosa","year":"2016","unstructured":"Lopez-Espinosa, M. J. et al. Perfluoroalkyl substances, sex hormones, and insulin-like growth factor-1 at 6-9 years of age: a cross-sectional analysis within the C8 Health Project. Environ. Health Perspect. 124, 1269\u20131275 (2016).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR53","doi-asserted-by":"publisher","first-page":"9140","DOI":"10.1021\/acs.est.3c01271","volume":"57","author":"Y Xing","year":"2023","unstructured":"Xing, Y. et al. Association between Serum Per- and Polyfluoroalkyl substance levels and risk of central and peripheral precocious puberty in girls. Environ. Sci. Technol. 57, 9140\u20139149 (2023).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR54","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.1021\/es1038694","volume":"45","author":"MJ Lopez-Espinosa","year":"2011","unstructured":"Lopez-Espinosa, M. J. et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ. Sci. Technol. 45, 8160\u20138166 (2011).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR55","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/humrep\/det382","volume":"28","author":"SL Kristensen","year":"2013","unstructured":"Kristensen, S. L. et al. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum. Reprod. 28, 3337\u20133348 (2013).","journal-title":"Hum. Reprod."},{"key":"5366_CR56","doi-asserted-by":"publisher","first-page":"97009","DOI":"10.1289\/EHP11811","volume":"131","author":"SM Pinney","year":"2023","unstructured":"Pinney, S. M. et al. Exposure to perfluoroalkyl substances and associations with pubertal onset and serum reproductive hormones in a longitudinal study of young girls in greater Cincinnati and the San Francisco Bay Area. Environ. Health Perspect. 131, 97009 (2023).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-025-01188-1","volume":"24","author":"N van Larebeke","year":"2025","unstructured":"van Larebeke, N. et al. Per- and Polyfluoroalkyl Substances (PFAS), thyroid hormones, sexual hormones and pubertal development in adolescents residing in the neighborhood of a 3m factory. Environ. Health 24, 34 (2025).","journal-title":"Environ. Health"},{"key":"5366_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5271\/sjweh.2908","volume":"36","author":"C Fei","year":"2010","unstructured":"Fei, C. et al. Maternal concentrations of perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) and duration of breastfeeding. Scand. J. Work Environ. Health 36, 413\u2013421 (2010).","journal-title":"Scand. J. Work Environ. Health"},{"key":"5366_CR59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.envres.2016.04.034","volume":"149","author":"ME Romano","year":"2016","unstructured":"Romano, M. E. et al. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environ. Res. 149, 239\u2013246 (2016).","journal-title":"Environ. Res"},{"key":"5366_CR60","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.reprotox.2016.07.010","volume":"68","author":"CA Timmermann","year":"2017","unstructured":"Timmermann, C. A. et al. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances. Reprod. Toxicol. 68, 164\u2013170 (2017).","journal-title":"Reprod. Toxicol."},{"key":"5366_CR61","doi-asserted-by":"crossref","unstructured":"Timmermann, C. A. et al. Pregnancy exposure to perfluoroalkyl substances, prolactin concentrations and breastfeeding in the Odense Child Cohort. J. Clin. Endocrinol. Metab. 107, e631\u2013e642 (2021).","DOI":"10.1210\/clinem\/dgab638"},{"key":"5366_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.164724","volume":"891","author":"LB Rokoff","year":"2023","unstructured":"Rokoff, L. B. et al. Plasma concentrations of Per- and Polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project VIVA. Sci. Total Environ. 891, 164724 (2023).","journal-title":"Sci. Total Environ."},{"key":"5366_CR63","doi-asserted-by":"crossref","unstructured":"Fenton, S. E. et al. Per- and Polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ. Toxicol. Chem. 40, 606\u2013630 (2020).","DOI":"10.1002\/etc.4890"},{"key":"5366_CR64","unstructured":"C8 Science Panel. The Science Panel Website. http:\/\/www.c8sciencepanel.org\/ (2013)."},{"key":"5366_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1289\/ehp.0901584","volume":"118","author":"D Melzer","year":"2010","unstructured":"Melzer, D. et al. Association between serum Perfluorooctanoic Acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 118, 686\u2013692 (2010).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR66","doi-asserted-by":"crossref","unstructured":"Xiao, C. et al. Associations of exposure to perfluoroalkyl substances with thyroid hormone concentrations and birth size. J. Clin. Endocrinol. Metab. 105, 735\u2013745 (2020).","DOI":"10.1210\/clinem\/dgz147"},{"key":"5366_CR67","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.envint.2019.04.023","volume":"129","author":"AJF Reardon","year":"2019","unstructured":"Reardon, A. J. F. et al. Longitudinal analysis reveals early-pregnancy associations between perfluoroalkyl sulfonates and thyroid hormone status in a Canadian prospective birth cohort. Environ. Int. 129, 389\u2013399 (2019).","journal-title":"Environ. Int."},{"key":"5366_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2021.129664","volume":"273","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Umbilical cord serum perfluoroalkyl substance mixtures in relation to thyroid function of newborns: findings from Sheyang Mini birth cohort study. Chemosphere 273, 129664 (2021).","journal-title":"Chemosphere"},{"key":"5366_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-020-00679-7","volume":"19","author":"H Liang","year":"2020","unstructured":"Liang, H. et al. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort. Environ. Health 19, 127 (2020).","journal-title":"Environ. Health"},{"key":"5366_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2020.105728","volume":"139","author":"EV Preston","year":"2020","unstructured":"Preston, E. V. et al. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project VIVA cohort: a mixtures approach. Environ. Int. 139, 105728 (2020).","journal-title":"Environ. Int."},{"key":"5366_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107420","volume":"167","author":"A Derakhshan","year":"2022","unstructured":"Derakhshan, A. et al. Association of per- and polyfluoroalkyl substances with thyroid homeostasis during pregnancy in the SELMA study. Environ. Int. 167, 107420 (2022).","journal-title":"Environ. Int."},{"key":"5366_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.113492","volume":"212","author":"RC Jensen","year":"2022","unstructured":"Jensen, R. C. et al. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort. Environ. Res. 212, 113492 (2022).","journal-title":"Environ. Res."},{"key":"5366_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116897","volume":"237","author":"A Rodriguez-Carrillo","year":"2023","unstructured":"Rodriguez-Carrillo, A. et al. Association of exposure to perfluoroalkyl substances (PFAS) and phthalates with thyroid hormones in adolescents from HBM4EU aligned studies.\u00a0Environ. Res. 237, 116897 (2023).","journal-title":"Environ. Res."},{"key":"5366_CR74","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1289\/ehp.1409589","volume":"124","author":"GM Webster","year":"2016","unstructured":"Webster, G. M. et al. Cross-sectional associations of serum perfluoroalkyl acids and thyroid hormones in U.S. adults: variation according to TPOAb and Iodine Status (NHANES 2007-2008). Environ. Health Perspect. 124, 935\u2013942 (2016).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR75","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1365-2826.2004.01243.x","volume":"16","author":"RT Zoeller","year":"2004","unstructured":"Zoeller, R. T. & Rovet, J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J. Neuroendocrinol. 16, 809\u2013818 (2004).","journal-title":"J. Neuroendocrinol."},{"key":"5366_CR76","doi-asserted-by":"crossref","unstructured":"Hu, W. et al. Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs) crossing the blood-cerebrospinal fluid barrier: their occurrence in human cerebrospinal fluid. J. Hazard Mater. 442, 130003 (2023).","DOI":"10.1016\/j.jhazmat.2022.130003"},{"key":"5366_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.129819","volume":"441","author":"MY Xie","year":"2023","unstructured":"Xie, M. Y. et al. Glioma is associated with exposure to legacy and alternative per- and polyfluoroalkyl substances. J. Hazard Mater. 441, 129819 (2023).","journal-title":"J. Hazard Mater."},{"key":"5366_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-14-2","volume":"14","author":"BB Hoyer","year":"2015","unstructured":"Hoyer, B. B. et al. Pregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years-a prospective study. Environ. Health 14, 2 (2015).","journal-title":"Environ. Health"},{"key":"5366_CR79","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.envres.2016.01.008","volume":"147","author":"AM Vuong","year":"2016","unstructured":"Vuong, A. M. et al. Prenatal polybrominated diphenyl ether and perfluoroalkyl substance exposures and executive function in school-age children. Environ. Res. 147, 556\u2013564 (2016).","journal-title":"Environ. Res."},{"key":"5366_CR80","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.envint.2016.09.015","volume":"97","author":"Y Oulhote","year":"2016","unstructured":"Oulhote, Y. et al. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances. Environ. Int. 97, 237\u2013245 (2016).","journal-title":"Environ. Int."},{"key":"5366_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.114322","volume":"215","author":"J Oh","year":"2022","unstructured":"Oh, J. et al. Childhood exposure to per- and polyfluoroalkyl substances and neurodevelopment in the charge case-control study. Environ. Res. 215, 114322 (2022).","journal-title":"Environ. Res."},{"key":"5366_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.137587","volume":"313","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. Prenatal perfluoroalkyl substances exposure and neurodevelopment in toddlers: findings from SMBCS. Chemosphere 313, 137587 (2023).","journal-title":"Chemosphere"},{"key":"5366_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107384","volume":"166","author":"F Luo","year":"2022","unstructured":"Luo, F. et al. Exposure to perfluoroalkyl substances and neurodevelopment in 2-year-old children: a prospective cohort study. Environ. Int. 166, 107384 (2022).","journal-title":"Environ. Int."},{"key":"5366_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116812","volume":"236","author":"XX Gao","year":"2023","unstructured":"Gao, X. X. et al. Association between prenatal exposure to per- and polyfluoroalkyl substances and neurodevelopment in children: evidence based on birth cohort. Environ. Res. 236, 116812 (2023).","journal-title":"Environ. Res."},{"key":"5366_CR85","doi-asserted-by":"crossref","unstructured":"Abdulkadir, A. et al. Epigenetic consequences of in utero PFAS exposure: implications for development and long-term health. Int. J. Environ. Res. Public Health 22, 917 (2025).","DOI":"10.3390\/ijerph22060917"},{"key":"5366_CR86","doi-asserted-by":"publisher","first-page":"115939","DOI":"10.1016\/j.ecoenv.2024.115939","volume":"271","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. Association of prenatal exposure to perfluorinated and polyfluoroalkyl substances with childhood neurodevelopment: a systematic review and meta-analysis. Ecotoxicol. Environ. Saf. 271, 115939 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"5366_CR87","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1021\/acs.est.2c06535","volume":"57","author":"Z Xie","year":"2023","unstructured":"Xie, Z. et al. Prenatal exposure to perfluoroalkyl substances and cognitive and neurobehavioral development in children at 6 years of age. Environ. Sci. Technol. 57, 8213\u20138224 (2023).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.107912","volume":"174","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Prenatal exposure to perfluoroalkyl substances and child intelligence quotient: evidence from the Shanghai birth cohort. Environ. Int. 174, 107912 (2023).","journal-title":"Environ. Int."},{"key":"5366_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2023.107182","volume":"98","author":"EA Enright","year":"2023","unstructured":"Enright, E. A. et al. Associations of prenatal exposure to per- and polyfluoroalkyl substances (PFAS) with measures of cognition in 7.5-month-old infants: an exploratory study. Neurotoxicol. Teratol. 98, 107182 (2023).","journal-title":"Neurotoxicol. Teratol."},{"key":"5366_CR90","doi-asserted-by":"crossref","unstructured":"Beck, I. H. et al. Association between prenatal and early postnatal exposure to perfluoroalkyl substances (PFAS) and IQ score in 7-year-old children from the Odense Child Cohort. Am. J. Epidemiol. 192, 1522\u20131535 (2023).","DOI":"10.1093\/aje\/kwad110"},{"key":"5366_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2023.107181","volume":"98","author":"CV Goodman","year":"2023","unstructured":"Goodman, C. V. et al. Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: the MIREC cohort. Neurotoxicol. Teratol. 98, 107181 (2023).","journal-title":"Neurotoxicol. Teratol."},{"key":"5366_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2020.106328","volume":"147","author":"J Oh","year":"2021","unstructured":"Oh, J. et al. Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study. Environ. Int. 147, 106328 (2021).","journal-title":"Environ. Int."},{"key":"5366_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.110825","volume":"195","author":"AM Vuong","year":"2021","unstructured":"Vuong, A. M. et al. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: the HOME study. Environ. Res. 195, 110825 (2021).","journal-title":"Environ. Res."},{"key":"5366_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111692","volume":"202","author":"TS Skogheim","year":"2021","unstructured":"Skogheim, T. S. et al. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit\/hyperactivity disorder and autism spectrum disorder in children. Environ. Res. 202, 111692 (2021).","journal-title":"Environ. Res."},{"key":"5366_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.125185","volume":"416","author":"C Carrizosa","year":"2021","unstructured":"Carrizosa, C. et al. Prenatal perfluoroalkyl substance exposure and neuropsychological development throughout childhood: the INMA project. J. Hazard Mater. 416, 125185 (2021).","journal-title":"J. Hazard Mater."},{"key":"5366_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111621","volume":"202","author":"MH Harris","year":"2021","unstructured":"Harris, M. H. et al. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems. Environ. Res. 202, 111621 (2021).","journal-title":"Environ. Res."},{"key":"5366_CR97","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/EDE.0000000000001587","volume":"34","author":"JL Ames","year":"2023","unstructured":"Ames, J. L. et al. Prenatal exposure to per- and polyfluoroalkyl substances and childhood autism-related outcomes. Epidemiology 34, 450\u2013459 (2023).","journal-title":"Epidemiology"},{"key":"5366_CR98","doi-asserted-by":"publisher","DOI":"10.1289\/EHP12540","volume":"131","author":"H Tillaut","year":"2023","unstructured":"Tillaut, H. et al. Prenatal exposure to perfluoroalkyl substances and child behavior at age 12: a PELAGIE mother-child cohort study. Environ. Health Perspect. 131, 117009 (2023).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-019-0493-3","volume":"18","author":"J Niu","year":"2019","unstructured":"Niu, J. et al. Prenatal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age. Environ. Health 18, 53 (2019).","journal-title":"Environ. Health"},{"key":"5366_CR100","doi-asserted-by":"publisher","DOI":"10.1289\/EHP1062","volume":"125","author":"N Matilla-Santander","year":"2017","unstructured":"Matilla-Santander, N. et al. Exposure to perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the Spanish INMA birth cohorts. Environ. Health Perspect. 125, 117004 (2017).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR101","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.fertnstert.2014.10.001","volume":"103","author":"C Zhang","year":"2015","unstructured":"Zhang, C. et al. A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes. Fertil. Steril. 103, 184\u2013189 (2015).","journal-title":"Fertil. Steril."},{"key":"5366_CR102","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.envint.2018.04.010","volume":"116","author":"RC Jensen","year":"2018","unstructured":"Jensen, R. C. et al. Perfluoroalkyl substances and glycemic status in pregnant Danish women: the Odense Child Cohort. Environ. Int 116, 101\u2013107 (2018).","journal-title":"Environ. Int"},{"key":"5366_CR103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.envint.2019.01.027","volume":"124","author":"ML Rahman","year":"2019","unstructured":"Rahman, M. L. et al. Persistent organic pollutants and gestational diabetes: a multi-center prospective cohort study of healthy US women. Environ. Int. 124, 249\u2013258 (2019).","journal-title":"Environ. Int."},{"key":"5366_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.envint.2019.03.035","volume":"127","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Structure-based investigation on the association between perfluoroalkyl acids exposure and both gestational diabetes mellitus and glucose homeostasis in pregnant women. Environ. Int. 127, 85\u201393 (2019).","journal-title":"Environ. Int."},{"key":"5366_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.120833","volume":"317","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus. Environ. Pollut. 317, 120833 (2023).","journal-title":"Environ. Pollut."},{"key":"5366_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.05.068","volume":"130","author":"B Eryasa","year":"2019","unstructured":"Eryasa, B. et al. Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances. Environ. Int. 130, 104874 (2019).","journal-title":"Environ. Int."},{"key":"5366_CR107","doi-asserted-by":"publisher","first-page":"105952","DOI":"10.1016\/j.envint.2020.105952","volume":"143","author":"H Xu","year":"2020","unstructured":"Xu, H. et al. Exposure to elevated per- and polyfluoroalkyl substances in early pregnancy is related to increased risk of gestational diabetes mellitus: a nested case-control study in Shanghai, China. Environ. Int. 143, 105952 (2020).","journal-title":"Environ. Int."},{"key":"5366_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2019.108775","volume":"179","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. Perfluoroalkyl substances and changes in bone mineral density: a prospective analysis in the POUNDS-LOST study. Environ. Res. 179, 108775 (2019).","journal-title":"Environ. Res."},{"key":"5366_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-018-0498-5","volume":"13","author":"Z Jeddy","year":"2018","unstructured":"Jeddy, Z. et al. Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17. Arch. Osteoporos. 13, 84 (2018).","journal-title":"Arch. Osteoporos."},{"key":"5366_CR110","doi-asserted-by":"publisher","first-page":"97011","DOI":"10.1289\/EHP9424","volume":"129","author":"JP Buckley","year":"2021","unstructured":"Buckley, J. P. et al. Associations of maternal serum perfluoroalkyl substances concentrations with early adolescent bone mineral content and density: the Health Outcomes and Measures of the Environment (HOME) Study. Environ. Health Perspect. 129, 97011 (2021).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR111","doi-asserted-by":"publisher","first-page":"87006","DOI":"10.1289\/EHP4918","volume":"127","author":"R Cluett","year":"2019","unstructured":"Cluett, R. et al. Per- and polyfluoroalkyl substance plasma concentrations and bone mineral density in midchildhood: a cross-sectional study (Project VIVA, United States). Environ. Health Perspect. 127, 87006 (2019).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-022-00929-w","volume":"21","author":"A Blomberg","year":"2022","unstructured":"Blomberg, A. et al. Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study. Environ. Health 21, 113 (2022).","journal-title":"Environ. Health"},{"key":"5366_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117611","volume":"244","author":"E Beglarian","year":"2024","unstructured":"Beglarian, E. et al. Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: a multi-cohort study. Environ. Res. 244, 117611 (2024).","journal-title":"Environ. Res."},{"key":"5366_CR114","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.taap.2016.04.002","volume":"301","author":"A Koskela","year":"2016","unstructured":"Koskela, A. et al. Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation. Toxicol. Appl. Pharm. 301, 14\u201321 (2016).","journal-title":"Toxicol. Appl. Pharm."},{"key":"5366_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07359-6","volume":"7","author":"A Koskela","year":"2017","unstructured":"Koskela, A. et al. Perfluoroalkyl substances in human bone: concentrations in bones and effects on bone cell differentiation. Sci. Rep. 7, 6841 (2017).","journal-title":"Sci. Rep."},{"key":"5366_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-021-01853-9","volume":"17","author":"L Sinisalu","year":"2021","unstructured":"Sinisalu, L. et al. Prenatal exposure to poly-\/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood. Metabolomics 17, 103 (2021).","journal-title":"Metabolomics"},{"key":"5366_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111400","volume":"200","author":"AJ Blomberg","year":"2021","unstructured":"Blomberg, A. J. et al. Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort. Environ. Res. 200, 111400 (2021).","journal-title":"Environ. Res."},{"key":"5366_CR118","unstructured":"National Toxicology Program. Monograph on immunotoxicity associated with exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). (National Toxicology Program, Research Triangle Park, NC, https:\/\/ntp.niehs.nih.gov\/ntp\/ohat\/pfoa_pfos\/pfoa_pfosmonograph_508.pdf, 2016)."},{"key":"5366_CR119","doi-asserted-by":"publisher","first-page":"e0205388","DOI":"10.1371\/journal.pone.0205388","volume":"13","author":"E Budtz-J\u00f8rgensen","year":"2018","unstructured":"Budtz-J\u00f8rgensen, E. & Grandjean, P. Application of benchmark analysis for mixed contaminant exposures: mutual adjustment of perfluoroalkylate substances associated with immunotoxicity. PLoS ONE 13, e0205388 (2018).","journal-title":"PLoS ONE"},{"key":"5366_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e08160","volume":"7","author":"H von Holst","year":"2021","unstructured":"von Holst, H. et al. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies. Heliyon 7, e08160 (2021).","journal-title":"Heliyon"},{"key":"5366_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119442","volume":"306","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Effects of exposure to per- and polyfluoroalkyl substances on vaccine antibodies: a systematic review and meta-analysis based on epidemiological studies. Environ. Pollut. 306, 119442 (2022).","journal-title":"Environ. Pollut."},{"key":"5366_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-022-00958-5","volume":"22","author":"V Ehrlich","year":"2023","unstructured":"Ehrlich, V. et al. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS). Environ. Health 22, 19 (2023).","journal-title":"Environ. Health"},{"key":"5366_CR123","unstructured":"U.S. Environmental Protection Agency. Technical Fact Sheet: Drinking Water Health Advisories for Four PFAS (PFOA, PFOS, GenX Chemicals, and PFBS). https:\/\/www.epa.gov\/system\/files\/documents\/2022-06\/technical-factsheet-four-PFAS.pdf. (2022)."},{"key":"5366_CR124","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.2034","volume":"307","author":"P Grandjean","year":"2012","unstructured":"Grandjean, P. et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307, 391\u2013397 (2012).","journal-title":"JAMA"},{"key":"5366_CR125","doi-asserted-by":"crossref","unstructured":"Mogensen, U. B. et al. Structural equation modeling of immunotoxicity associated with exposure to perfluorinated compounds. Environ. Health 14, 47 (2015).","DOI":"10.1186\/s12940-015-0032-9"},{"key":"5366_CR126","first-page":"1","volume":"16","author":"European Food Safety Authority","year":"2018","unstructured":"European Food Safety Authority. Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA J. 16, 1\u2013284\u00a0https:\/\/efsa.onlinelibrary.wiley.com\/doi\/epdf\/10.2903\/j.efsa.2018.5194 (2018).","journal-title":"EFSA J."},{"key":"5366_CR127","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00204-020-02715-4","volume":"94","author":"K Abraham","year":"2020","unstructured":"Abraham, K. et al. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch. Toxicol. 94, 2131\u20132147 (2020).","journal-title":"Arch. Toxicol."},{"key":"5366_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-023-00985-w","volume":"22","author":"E Budtz-Jorgensen","year":"2023","unstructured":"Budtz-Jorgensen, E. & Grandjean, P. Benchmark dose calculations for PFAS exposure based on two data sets on immunotoxic effects. Environ. Health 22, 40 (2023).","journal-title":"Environ. Health"},{"key":"5366_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/1547691X.2017.1360968","volume":"14","author":"P Grandjean","year":"2017","unstructured":"Grandjean, P. et al. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-Years. J. Immunotoxicol. 14, 188\u2013195 (2017).","journal-title":"J. Immunotoxicol."},{"key":"5366_CR130","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.1021\/acs.est.5b02237","volume":"49","author":"UB Mogensen","year":"2015","unstructured":"Mogensen, U. B. et al. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ. Sci. Technol. 49, 10466\u201310473 (2015).","journal-title":"Environ. Sci. Technol."},{"key":"5366_CR131","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00204-025-03980-x","volume":"99","author":"N Gonzalez","year":"2025","unstructured":"Gonzalez, N. & Domingo, J. L. PFC\/PFAS concentrations in human milk and infant exposure through lactation: a comprehensive review of the scientific literature. Arch. Toxicol. 99, 1843\u20131864 (2025).","journal-title":"Arch. Toxicol."},{"key":"5366_CR132","doi-asserted-by":"publisher","first-page":"115042","DOI":"10.1016\/j.envres.2022.115042","volume":"219","author":"JS LaKind","year":"2023","unstructured":"LaKind, J. S. et al. Per- and Polyfluoroalkyl Substances (Pfas) in breast milk and infant formula: a global issue. Environ. Res. 219, 115042 (2023).","journal-title":"Environ. Res."},{"key":"5366_CR133","unstructured":"National Academies of Sciences, Engineering, and Medicine. Understanding Breastfeeding Promotion, Initiation and Support across the United States: An Analysis (The National Academies Press, 2025)."},{"key":"5366_CR134","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/1547691X.2012.755580","volume":"10","author":"B Granum","year":"2013","unstructured":"Granum, B. et al. Prenatal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J. Immunotoxicol. 10, 373\u2013379 (2013).","journal-title":"J. Immunotoxicol."},{"key":"5366_CR135","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.envint.2018.12.041","volume":"124","author":"A Impinen","year":"2019","unstructured":"Impinen, A. et al. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MOBA) cohort. Environ. Int 124, 462\u2013472 (2019).","journal-title":"Environ. Int"},{"key":"5366_CR136","doi-asserted-by":"publisher","first-page":"106395","DOI":"10.1016\/j.envint.2021.106395","volume":"149","author":"L Dalsager","year":"2021","unstructured":"Dalsager, L. et al. Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: a study among 1,503 children from the Odense Child Cohort. Environ. Int. 149, 106395 (2021).","journal-title":"Environ. Int."},{"key":"5366_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.110156","volume":"191","author":"H Huang","year":"2020","unstructured":"Huang, H. et al. Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children. Environ. Res. 191, 110156 (2020).","journal-title":"Environ. Res."},{"key":"5366_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2021.133235","volume":"289","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Association between maternal serum concentration of perfluoroalkyl substances (PFASs) at delivery and acute infectious diseases in infancy. Chemosphere 289, 133235 (2022).","journal-title":"Chemosphere"},{"key":"5366_CR139","doi-asserted-by":"publisher","first-page":"87002","DOI":"10.1289\/EHP6517","volume":"128","author":"CA Timmermann","year":"2020","unstructured":"Timmermann, C. A. et al. Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of Guinea-Bissau Children. Environ. Health Perspect. 128, 87002 (2020).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107239","volume":"164","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Association between serum per- and polyfluoroalkyl substances concentrations and common cold among children and adolescents in the United States. Environ. Int. 164, 107239 (2022).","journal-title":"Environ. Int."},{"key":"5366_CR141","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.envint.2016.08.026","volume":"96","author":"L Dalsager","year":"2016","unstructured":"Dalsager, L. et al. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4 years among 359 children in the Odense Child Cohort. Environ. Int. 96, 58\u201364 (2016).","journal-title":"Environ. Int."},{"key":"5366_CR142","doi-asserted-by":"publisher","first-page":"116619","DOI":"10.1016\/j.envpol.2021.116619","volume":"275","author":"CM Bulka","year":"2021","unstructured":"Bulka, C. M., Avula, V. & Fry, R. C. Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: recent findings from NHANES 1999-2016. Environ. Pollut. 275, 116619 (2021).","journal-title":"Environ. Pollut."},{"key":"5366_CR143","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.envres.2010.08.004","volume":"110","author":"C Fei","year":"2010","unstructured":"Fei, C. et al. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ. Res. 110, 773\u2013777 (2010).","journal-title":"Environ. Res."},{"key":"5366_CR144","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/1547691X.2015.1067259","volume":"13","author":"K Kielsen","year":"2016","unstructured":"Kielsen, K. et al. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J. Immunotoxicol. 13, 270\u2013273 (2016).","journal-title":"J. Immunotoxicol."},{"key":"5366_CR145","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/toxsci\/kft269","volume":"138","author":"C Looker","year":"2014","unstructured":"Looker, C. et al. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol. Sci. 138, 76\u201388 (2014).","journal-title":"Toxicol. Sci."},{"key":"5366_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117499","volume":"240","author":"T Atagi","year":"2024","unstructured":"Atagi, T. et al. Associations between prenatal exposure to per- and polyfluoroalkyl substances and wheezing and asthma symptoms in 4-year-old children: the Japan Environment and Children\u2019s Study. Environ. Res. 240, 117499 (2024).","journal-title":"Environ. Res."},{"key":"5366_CR147","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1547691X.2016.1254306","volume":"14","author":"CA Timmermann","year":"2017","unstructured":"Timmermann, C. A. et al. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J. Immunotoxicol. 14, 39\u201349 (2017).","journal-title":"J. Immunotoxicol."},{"key":"5366_CR148","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/oemed-2014-102364","volume":"72","author":"K Steenland","year":"2015","unstructured":"Steenland, K., Zhao, L. & Winquist, A. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occup. Environ. Med. 72, 373\u2013380 (2015).","journal-title":"Occup. Environ. Med."},{"key":"5366_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-023-01019-1","volume":"22","author":"Y He","year":"2023","unstructured":"He, Y. et al. Association of perfluoroalkyl and polyfluoroalkyl substances (PFASs) exposures and the risk of systemic lupus erythematosus: a case-control study in China. Environ. Health 22, 78 (2023).","journal-title":"Environ. Health"},{"key":"5366_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119505","volume":"307","author":"J Qu","year":"2022","unstructured":"Qu, J. et al. Evaluated serum perfluoroalkyl acids and their relationships with the incidence of rheumatoid arthritis in the general population in Hangzhou, China. Environ. Pollut. 307, 119505 (2022).","journal-title":"Environ. Pollut."},{"key":"5366_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.134338","volume":"298","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Per-\/polyfluoroalkyl substance concentrations in human serum and their associations with immune markers of rheumatoid arthritis. Chemosphere 298, 134338 (2022).","journal-title":"Chemosphere"},{"key":"5366_CR152","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2019.03.002","volume":"330","author":"C Ammitzboll","year":"2019","unstructured":"Ammitzboll, C. et al. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. J. Neuroimmunol. 330, 90\u201395 (2019).","journal-title":"J. Neuroimmunol."},{"key":"5366_CR153","unstructured":"IARC. Perfluorooctanoic acid, in IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans Vol. 110 37\u2013110 (International Agency for Research on Cancer, 2016)."},{"key":"5366_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.115188","volume":"220","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure. Environ. Res. 220, 115188 (2023).","journal-title":"Environ. Res."},{"key":"5366_CR155","doi-asserted-by":"crossref","unstructured":"Temkin, A. M., Hocevar, B. A., Andrews, D. Q., Naidenko, O. V. & Kamendulis, L. M. Application of the Key characteristics of carcinogens to per and polyfluoroalkyl substances. Int. J. Environ. Res. Public Health 17, 1668 (2020).","DOI":"10.3390\/ijerph17051668"},{"key":"5366_CR156","unstructured":"National Toxicology Program. NTP technical report on the toxicology and carcinogenesis studies of perfluorooctanoic acid (CAS No. 335-67-1) administered in feed to Sprague-Dawley rats (Revised). (National Institute for Environmental Health Sciences, Raleigh, NC, 2023)."},{"key":"5366_CR157","unstructured":"IARC. Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS), Vol. 135 (International Agency for Research on Cancer, 2025)."},{"key":"5366_CR158","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1097\/EE9.0000000000000365","volume":"9","author":"NR Binczewski","year":"2025","unstructured":"Binczewski, N. R. et al. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) from contaminated water and risk of childhood cancer in California, 2000-2015. Environ. Epidemiol. 9, e365 (2025).","journal-title":"Environ. Epidemiol."},{"key":"5366_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117435","volume":"240","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Neonatal per- and polyfluoroalkyl substance exposure in relation to retinoblastoma. Environ. Res 240, 117435 (2024).","journal-title":"Environ. Res"},{"key":"5366_CR160","doi-asserted-by":"publisher","first-page":"107425","DOI":"10.1016\/j.envint.2022.107425","volume":"167","author":"K Steenland","year":"2022","unstructured":"Steenland, K. et al. Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies. Environ. Int. 167, 107425 (2022).","journal-title":"Environ. Int."},{"key":"5366_CR161","doi-asserted-by":"publisher","first-page":"110690","DOI":"10.1016\/j.envres.2020.110690","volume":"194","author":"K Steenland","year":"2021","unstructured":"Steenland, K. & Winquist, A. PFAS and cancer, a scoping review of the epidemiologic evidence. Environ. Res. 194, 110690 (2021).","journal-title":"Environ. Res."},{"key":"5366_CR162","doi-asserted-by":"crossref","unstructured":"Shearer, J. J. et al. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. J. Natl. Cancer Inst. 113, 580\u2013587 (2020).","DOI":"10.1093\/jnci\/djaa143"},{"key":"5366_CR163","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.envint.2013.10.005","volume":"63","author":"E Hardell","year":"2014","unstructured":"Hardell, E. et al. Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer. Environ. Int. 63, 35\u201339 (2014).","journal-title":"Environ. Int."},{"key":"5366_CR164","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djp041","volume":"101","author":"KT Eriksen","year":"2009","unstructured":"Eriksen, K. T. et al. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J. Natl. Cancer Inst. 101, 605\u2013609 (2009).","journal-title":"J. Natl. Cancer Inst."},{"key":"5366_CR165","unstructured":"Raleigh, K. K. Cancer Mortality in 3M Chemical Workers PhD thesis, University of Minnesota, (2013)."},{"key":"5366_CR166","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.annepidem.2007.01.036","volume":"17","author":"BH Alexander","year":"2007","unstructured":"Alexander, B. H. & Olsen, G. W. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann. Epidemiol. 17, 471\u2013478 (2007).","journal-title":"Ann. Epidemiol."},{"key":"5366_CR167","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/eurpub\/ckx066","volume":"28","author":"M Mastrantonio","year":"2018","unstructured":"Mastrantonio, M. et al. Drinking water contamination from perfluoroalkyl substances (PFAS): an ecological mortality study in the Veneto Region, Italy. Eur. J. Public Health 28, 180\u2013185 (2018).","journal-title":"Eur. J. Public Health"},{"key":"5366_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-022-00895-3","volume":"21","author":"X Li","year":"2022","unstructured":"Li, X. et al. Perfluoroalkyl substances (Pfass) as risk factors for breast cancer: a case-control study in Chinese population. Environ. Health 21, 83 (2022).","journal-title":"Environ. Health"},{"key":"5366_CR169","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1289\/ehp.1205829","volume":"121","author":"VM Vieira","year":"2013","unstructured":"Vieira, V. M. et al. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ. Health Perspect. 121, 318\u2013323 (2013).","journal-title":"Environ. Health Perspect."},{"key":"5366_CR170","doi-asserted-by":"publisher","first-page":"108743","DOI":"10.1016\/j.envres.2019.108743","volume":"179","author":"P Girardi","year":"2019","unstructured":"Girardi, P. & Merler, E. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid. Environ. Res. 179, 108743 (2019).","journal-title":"Environ. Res."},{"key":"5366_CR171","unstructured":"Sunding, D. L. Damage to Minnesota\u2019s natural resources resulting from 3M\u2019s disposal of PFCs in Washington County, MN. (State of Minnesota District Court for the County of Hennepin Fourth Judicial District, Civil Action No. 27-cv-10-28862, State of Minnesota, et al. v. 3M company, Minneapolis, MN, 2017)."},{"key":"5366_CR172","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ijc.34487","volume":"153","author":"VC Chang","year":"2023","unstructured":"Chang, V. C. et al. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: an analysis in the prostate, lung, colorectal and ovarian cancer screening trial. Int. J. Cancer 153, 775\u2013782 (2023).","journal-title":"Int. J. Cancer"},{"key":"5366_CR173","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1476-072X-10-32","volume":"10","author":"S St-Hilaire","year":"2011","unstructured":"St-Hilaire, S. et al. Estrogen receptor positive breast cancers and their association with environmental factors. Int. J. Health Geogr. 10, 32 (2011).","journal-title":"Int. J. Health Geogr."},{"key":"5366_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117529","volume":"240","author":"J Cui","year":"2024","unstructured":"Cui, J. et al. Associations of exposure to per- and polyfluoroalkyl substances mixture with the numbers of lymph nodes in colorectal cancer patients. Environ. Res. 240, 117529 (2024).","journal-title":"Environ. Res."},{"key":"5366_CR175","doi-asserted-by":"crossref","unstructured":"Zheng, J. et al. Perfluorooctanesulfonic acid and perfluorooctanoic acid promote migration of three-dimensional colorectal cancer spheroids. Environ. Sci. Technol. 57, 21016\u201321028 (2023).","DOI":"10.1021\/acs.est.3c04844"},{"key":"5366_CR176","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41370-023-00601-6","volume":"33","author":"AL Cathey","year":"2023","unstructured":"Cathey, A. L. et al. Exploratory profiles of phenols, parabens, and per- and poly-fluoroalkyl substances among NHANES study participants in association with previous cancer diagnoses. J. Expo. Sci. Environ. Epidemiol. 33, 687\u2013698 (2023).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"5366_CR177","unstructured":"Lerner, S. 3M Knew About the Dangers of PFOA and PFOS Decades Ago, Internal Documents Show, https:\/\/theintercept.com\/2018\/07\/31\/3m-pfas-minnesota-pfoa-pfos\/ (2018)."},{"key":"5366_CR178","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5334\/aogh.4013","volume":"89","author":"N Gaber","year":"2023","unstructured":"Gaber, N., Bero, L. & Woodruff, T. J. The devil they knew: chemical documents analysis of industry influence on PFAS science. Ann. Glob. Health 89, 37 (2023).","journal-title":"Ann. Glob. Health"},{"key":"5366_CR179","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/2171050b0","volume":"217","author":"DR Taves","year":"1968","unstructured":"Taves, D. R. Evidence that there are two forms of fluoride in human serum. Nature 217, 1050\u20131051 (1968).","journal-title":"Nature"},{"key":"5366_CR180","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0021-9258(18)65805-3","volume":"219","author":"GL Nordby","year":"1956","unstructured":"Nordby, G. L. & Luck, J. M. Perfluorooctanoic acid interactions with human serum albumin. J. Biol. Chem. 219, 399\u2013404 (1956).","journal-title":"J. Biol. Chem."},{"key":"5366_CR181","doi-asserted-by":"crossref","unstructured":"Guy, W. S., Taves, D. R. & Brey, W. S. Organic fluorocompounds in human-plasma - prevalence and characterization. ACS Symposium Series, 28, 117\u2013134 (1976).","DOI":"10.1021\/bk-1976-0028.ch007"},{"key":"5366_CR182","unstructured":"Bilott, R. & Shroder, T. Exposure: Poisoned Water, Corporate Greed, and One Lawyer\u2019s Twenty-Year Battle against Dupont. (Simon & Schuster, 2019)."},{"key":"5366_CR183","unstructured":"Clapp, R., Hoppin, P. Perfluorooctanoic Acid. Defending Science. http:\/\/www.defendingscience.org\/case-studies\/perfluorooctanoic-acid (2011)."},{"key":"5366_CR184","unstructured":"Goldenthal, E. I., Jessup, D. C., Geil, R. G. & Mehring, J. S. Ninety-day subacute Rhesus monkey toxicity study, U.S. EPA Administrative Record, AR226-0447 (International Research and Development Corporation, 1978)."},{"key":"5366_CR185","unstructured":"Gilliland, F. D. Fluorocarbons and Human Health: Studies in an Occupational Cohort. Ph.D. in Environmental Health thesis, University of Minnesota, (1992)."},{"key":"5366_CR186","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/15298668091425301","volume":"41","author":"FD Griffith","year":"1980","unstructured":"Griffith, F. D. & Long, J. E. Animal toxicity studies with ammonium perfluorooctanoate. Am. Ind. Hyg. Assoc. J. 41, 576\u2013583 (1980).","journal-title":"Am. Ind. Hyg. Assoc. J."},{"key":"5366_CR187","unstructured":"Lerner, S. The Teflon Toxin: Dupont and the Chemistry of Deception, https:\/\/theintercept.com\/2015\/08\/11\/dupont-chemistry-deception\/ (2015)."},{"key":"5366_CR188","doi-asserted-by":"crossref","unstructured":"Grandjean, P. Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances. Environ. Health 17, 62 (2018).","DOI":"10.1186\/s12940-018-0405-y"},{"key":"5366_CR189","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/oemed-2014-102109","volume":"71","author":"KK Raleigh","year":"2014","unstructured":"Raleigh, K. K. et al. Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occup. Environ. Med. 71, 500\u2013506 (2014).","journal-title":"Occup. Environ. Med."},{"key":"5366_CR190","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.jom.0000052958.59271.10","volume":"45","author":"GW Olsen","year":"2003","unstructured":"Olsen, G. W. et al. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 45, 260\u2013270 (2003).","journal-title":"J. Occup. Environ. Med."},{"key":"5366_CR191","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1097\/JOM.0000000000001411","volume":"60","author":"P Grandjean","year":"2018","unstructured":"Grandjean, P. Health status of workers exposed to perfluorinated alkylate substances. J. Occup. Environ. Med 60, e562 (2018).","journal-title":"J. Occup. Environ. Med"},{"key":"5366_CR192","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1097\/JOM.0000000000001410","volume":"60","author":"GW Olsen","year":"2018","unstructured":"Olsen, G. W. Re: Health status of workers exposed to perfluorinated alkylate substances. J. Occup. Environ. Med 60, e563\u2013e566 (2018).","journal-title":"J. Occup. Environ. Med"},{"key":"5366_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-021-00771-6","volume":"20","author":"CL Soskolne","year":"2021","unstructured":"Soskolne, C. L. et al. Toolkit for detecting misused epidemiological methods. Environ. Health 20, 90 (2021).","journal-title":"Environ. Health"},{"key":"5366_CR194","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1210\/en.2015-1350","volume":"156","author":"P Grandjean","year":"2015","unstructured":"Grandjean, P. et al. Life-long implications of developmental exposure to environmental stressors: new perspectives. Endocrinology 156, 3408\u20133415 (2015).","journal-title":"Endocrinology"},{"key":"5366_CR195","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41370-018-0110-5","volume":"29","author":"HM Goeden","year":"2019","unstructured":"Goeden, H. M., Greene, C. W. & Jacobus, J. A. A transgenerational toxicokinetic model and its use in derivation of Minnesota PFOA water guidance. J. Expo. Sci. Environ. Epidemiol. 29, 183\u2013195 (2019).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"5366_CR196","unstructured":"European Environment Agency. Late lessons from early warnings: the precautionary principle 1896-2000 (Copenhagen, 2001)."},{"key":"5366_CR197","unstructured":"U.S. Environmental Protection Agency. PFOA & PFOS Drinking Water Health Advisories. Report No. EPA 800-F-16-003, (U.S. Environmental Protection Agency Office of Water, 2016)."},{"key":"5366_CR198","unstructured":"Agency for Toxic Substances and Disease Registry. Draft toxicological profile for perfluoroalkyls. (Centers for Disease Control, 2018)."},{"key":"5366_CR199","unstructured":"European Chemicals Agency. Risk to human health related to the presence of perfluoroalkyl substances in food. (European Chemicals Agency (ECHA), Helsinki, 2020)."},{"key":"5366_CR200","first-page":"32","volume":"86","author":"CA Wendel","year":"2024","unstructured":"Wendel, C. A., Hansen, L. & Bernstein, A. PFAS information for clinicians from ATSDR. J. Environ. Health 86, 32\u201334 (2024).","journal-title":"J. Environ. Health"},{"key":"5366_CR201","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/oby.24284","volume":"33","author":"BA Cohn","year":"2025","unstructured":"Cohn, B. A. et al. Grandmaternal perinatal serum polychlorinated biphenyls and prevalence of obesity in adult daughters and granddaughters. Obesity 33, 1165\u20131175 (2025).","journal-title":"Obesity"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05366-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:03:06Z","timestamp":1791378186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05366-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":201,"alternative-id":["5366"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05366-w","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}